Intellectual Property
Jun. 5, 2015
Divided infringement challenges for personalized medicine
The Federal Circuit has essentially restored a 2008 holding about when a defendant is not liable for direct infringement for customer behavior. By Kevin Kabler
On remand from the U.S. Supreme Court, the U.S. Court of Appeals for the Federal Circuit
last month held in Akamai Tech. Inc. v. Limelight Networks Inc. that "direct infringement liability of a method claim under 35 U.S.C. Section 271(a)
exists when all of the steps of the claim are performed by or attributed to a single
entity." In addition, the Federal Circuit ruled that direct ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In